As of May 27
| +0.88 / +1.19%|
The 4 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 74.00, with a high estimate of 80.00 and a low estimate of 67.00. The median estimate represents a -0.78% decrease from the last price of 74.58.
The current consensus among 5 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.